Ob/Gyn Medical News about Endometriosis-Associated Pain; Intramuscular Depot Medroxyprogesterone Acetate

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Interval of Injections of Intramuscular Depot Medroxyprogesterone Acetate in the Long-Term Treatment of Endometriosis-Associated Pain: A Randomized Comparative Trial
Gynecologic and Obstetric Investigation, 06/29/09

Cheewadhanaraks S et al. - At months 3, 6, 9, 12 and 15 of the treatment phase, there was no statistically significant difference of percentages of patients with satisfaction between the two regimens. The optimal interval of injections of depot medroxyprogesterone acetate 150 mg is every 3 months.

<< Previous
Incidence and Risk Factors for Newborn Umbilical Cord Infections...

Next >>
An observational prospective cohort study of incidence and...